Characterizing dual wavelength polarimetry through the eye for monitoring glucose.
Diabetes is an insidious disease that afflicts millions of people worldwide and typically requires the person with the disease to monitor their blood sugar level via finger or forearm sticks multiple times daily. Therefore, the ability to noninvasively measure glucose would be a significant advancement for the diabetic community. The use of optically polarized light passed through the anterior chamber of the eye is one proposed noninvasive approach for glucose monitoring. However, the birefringence of the cornea and the difficulty in coupling the light across the eye have been major drawbacks toward realizing this approach. A dual wavelength optical polarimetric approach has been proposed as a means to potentially overcome the birefringence noise but has never been fully characterized. Therefore, in this paper an optical model has been developed along with experiments performed on New Zealand White rabbit eyes for characterizing the light path and corneal birefringence at two different wavelengths as they are passed through the anterior chamber of the eye. The results show that, without index matching, it is possible to couple the light in and out of the eye but only across a very limited range otherwise the light does not come back out of the eye. It was also shown that there is potential to use a dual wavelength approach to accommodate the birefringence noise of the cornea in the presence of eye motion. These results will be used to help guide the final design of the polarimetric system for use in noninvasive monitoring of glucose in vivo.
Department of Biomedical Engineering, Texas A&M University, 337 Zachry Engineering Center, 3120 TAMU, College Station, TX 77843-3120.
Bilal H
BH
Malik
Gerard L
GL
Coté
Ophthalmic Physiol Opt. 2003 Jul;23(4):361-9
12828626
Opt Express. 2008 Sep 1;16(18):13738-51
18772985
Optom Vis Sci. 1990 Jun;67(6):391-9
2199882
Diabetes Technol Ther. 2001 Summer;3(2):201-7
11478325
Comp Biochem Physiol A Comp Physiol. 1975 May 1;51(1A):89-94
236894
J Biomed Opt. 2005 May-Jun;10(3):031114
16229639
Diabetes Technol Ther. 2000 Spring;2(1):5-16
11467321
Phys Med Biol. 2003 Jul 7;48(13):2023-32
12884933
J Opt Soc Am A Opt Image Sci Vis. 2005 Sep;22(9):1981-92
16211827
Bull Soc Belge Ophtalmol. 2006;(302):153-68
17265796
Graefes Arch Clin Exp Ophthalmol. 2004 Dec;242(12):1017-23
15592870
J Biomed Opt. 2010 Jan-Feb;15(1):017002
20210476
Appl Opt. 2000 Sep 1;39(25):4715-20
18350063
Anal Bioanal Chem. 1996 Jun;355(3-4):327-8
15045401
Exp Biol Med (Maywood). 2006 Sep;231(8):1323-32
16946401
Appl Opt. 1998 Jun 1;37(16):3553-7
18273323
Ophthalmic Physiol Opt. 2007 May;27(3):256-64
17470238
J Biomed Opt. 2006 Nov-Dec;11(6):064022
17212545
IEEE Trans Biomed Eng. 1997 Dec;44(12):1221-7
9401221
J Opt Soc Am A Opt Image Sci Vis. 1995 Jul;12(7):1425-38
7608787
Diabetes Technol Ther. 1999 Summer;1(2):135-43
11475285
Appl Opt. 2007 Jun 1;46(16):3359-68
17514294
J Biomed Opt. 2008 Mar-Apr;13(2):021112
18465961
Diabetes Technol Ther. 2003;5(5):807-16
14633346
J Biomed Opt. 2010 May-Jun;15(3):037012
20615041
Invest Ophthalmol Vis Sci. 2002 Jan;43(1):82-6
11773016
Vision Res. 1981;21(9):1413-21
7314525
Opt Lett. 2001 Jul 1;26(13):992-4
18040511
Diabetes Care. 1982 May-Jun;5(3):254-8
7172992
Diabetes Care. 1982 May-Jun;5(3):259-65
6890893
J Opt Soc Am A Opt Image Sci Vis. 1997 Aug;14(8):1684-95
9248060
J Biomed Opt. 2004 Jan-Feb;9(1):103-15
14715061
Diabetes Technol Ther. 2007 Feb;9(1):68-74
17316100
IEEE Trans Biomed Eng. 1992 Jul;39(7):752-6
1516942
Acta Ophthalmol (Copenh). 1966;:Suppl 88:1-80
5952890
J Opt Soc Am A. 1987 Jan;4(1):82-90
3559783
Br J Ophthalmol. 1950 Apr;34(4):201-11
15411483